ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,424.20
0.05%
Dow Jones
39,806.77
-0.49%
Gold vs US Dollar
2,429.40
0.41%
Brent Oil
83.53
-0.08%
Bitcoin
69,710.26
5.19%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Immunic Inc (IMUX) Share Price

IMUX Immunic Inc

1.26
0.015 (1.20%)
After Hours
Last Updated: 23:02:34
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Immunic Inc NASDAQ:IMUX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.015 1.20 1.26 1.25 1.32 1.34 1.23 1.24 211,016 22:02:34   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -93.61M -1.0410 -1.24 116.01M
 Type  Size  Price  Time  Units 
 20 100 1.26 22:02:34 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore IMUX News
08/05/202412:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/05/202411:45EDGAR2Form 8-K - Current report
08/05/202411:30PRNUSImmunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
06/05/202411:30PRNUSImmunic to Participate in Investor and Scientific Conferences in May
01/05/202411:30PRNUSImmunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
30/04/202411:30PRNUSImmunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation
04/04/202411:30PRNUSImmunic to Host MS R&D Day and Participate in Investor Conferences in April
Period
Draw mode
Data Downloads for IMUX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Immunic Inc Articles